Your browser doesn't support javascript.
loading
DNGR-1-mediated cross-presentation of dead cell-associated antigens.
Henry, Conor M; Castellanos, Carlos A; Reis e Sousa, Caetano.
Afiliação
  • Henry CM; Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Castellanos CA; Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Reis e Sousa C; Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: caetano@crick.ac.uk.
Semin Immunol ; 66: 101726, 2023 03.
Article em En | MEDLINE | ID: mdl-36758378
Conventional dendritic cells type 1 (cDC1) are critical for inducing protective CD8+ T cell responses to tumour and viral antigens. In many instances, cDC1 access those antigens in the form of material internalised from dying tumour or virally-infected cells. How cDC1 extract dead cell-associated antigens and cross-present them in the form of peptides bound to MHC class I molecules to CD8+ T cells remains unclear. Here we review the biology of dendritic cell natural killer group receptor-1 (DNGR-1; also known as CLEC9A), a C-type lectin receptor highly expressed on cDC1 that plays a key role in this process. We highlight recent advances that support a function for DNGR-1 signalling in promoting inducible rupture of phagocytic or endocytic compartments containing dead cell debris, thereby making dead cell-associated antigens accessible to the endogenous MHC class I processing and presentation machinery of cDC1. We further review how DNGR-1 detects dead cells, as well as the functions of the receptor in anti-viral and anti-tumour immunity. Finally, we highlight how the study of DNGR-1 has opened new perspectives into cross-presentation, some of which may have applications in immunotherapy of cancer and vaccination against viral diseases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apresentação Cruzada / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apresentação Cruzada / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Immunol Ano de publicação: 2023 Tipo de documento: Article